SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-028938
Filing Date
2016-11-10
Accepted
2016-11-10 16:23:54
Documents
63
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mcrb-10q_20160930.htm 10-Q 2053799
2 EX-31.1 mcrb-ex311_9.htm EX-31.1 9226
3 EX-31.2 mcrb-ex312_6.htm EX-31.2 9217
4 EX-32.1 mcrb-ex321_8.htm EX-32.1 7627
5 EX-32.2 mcrb-ex322_10.htm EX-32.2 7644
  Complete submission text file 0001564590-16-028938.txt   6566794

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mcrb-20160930.xml EX-101.INS 1493220
7 XBRL TAXONOMY EXTENSION SCHEMA mcrb-20160930.xsd EX-101.SCH 40184
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mcrb-20160930_cal.xml EX-101.CAL 39275
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mcrb-20160930_def.xml EX-101.DEF 106011
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mcrb-20160930_lab.xml EX-101.LAB 304232
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mcrb-20160930_pre.xml EX-101.PRE 228539
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37465 | Film No.: 161988353
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences